SA
DFTX

Sanctuary Advisors’s Definium Therapeutics DFTX Stock Holding History

Sanctuary Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Buy
11,466
+749
+7% +$12.7K ﹤0.01% 2318
2025
Q4 		$144K Sell
10,717
-948
-8% -$11.7K ﹤0.01% 2320
2025
Q3 		$138K Buy
11,665
+4
+0% +$37 ﹤0.01% 2315
2025
Q2 		$75.7K Buy
11,661
+329
+3% +$2.16K ﹤0.01% 2287
2025
Q1 		$66.3K Buy
11,332
+330
+3% +$2.36K ﹤0.01% 2129
2024
Q4 		$78.4K Sell
11,002
-5,000
-31% -$34.4K ﹤0.01% 2332
2024
Q3 		$121K Buy
+16,002
New +$111K ﹤0.01% 2296

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanctuary Advisors's DFTX Position: Q1 2026 in Review

Sanctuary Advisors increased its Definium Therapeutics (DFTX) stake by 7% in Q1 2026, buying an estimated $12.7K and bringing the position to 11,466 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #2318.

Sanctuary Advisors first reported a position in DFTX in Q3 2024 and has held it in 7 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Sanctuary Advisors held 11,466 shares of Definium Therapeutics worth $217K as of Q1 2026.
  • Sanctuary Advisors bought 749 Definium Therapeutics shares in Q1 2026, an estimated $12.7K.
  • Definium Therapeutics made up ﹤0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #2318 holding.
  • Sanctuary Advisors first reported a position in Definium Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.